A gear-driven infusion assembly is provided which has a housing, a gear assembly coupled to the housing, a shuttle assembly slidably coupled to the housing and operably coupled to the gear assembly, and a tube enclosure connected to the housing. The tube enclosure is configured to house a primary drug closure such as a syringe. The gear assembly includes a spool assembly having a pinion gear and a drive spool. When the spring rotates the drive spool, the drive spool drives the pinion gear, and the gear assembly drives the shuttle assembly. When the gear assembly drives the shuttle assembly, the shuttle assembly slides longitudinally along the housing. The gear assembly may be spring driven such that a spring rotates the pinion gear about the drive spool. An overspeed protection device is also provided which has a spool assembly including a drive spool.

Devices for delivering pharmaceutical formulations into the eye are described. The devices may be integrated to include features that allow safe and atraumatic manipulation of the devices with one hand. For example, accurate placement, including proper angulation, of the device on the eye and injection of a pharmaceutical formulation into the eye can be performed using one hand. The devices may also include improved safety features. For example, the devices may include an actuation mechanism that controls the rate and depth of injection into the eye. Some devices include a dynamic resistance component capable of adjusting the amount of pressure applied to the eye surface. Related methods and systems comprising the devices are also described.

A gear-driven infusion assembly is provided which has a housing, a gear assembly coupled to the housing, a shuttle assembly slidably coupled to the housing and operably coupled to the gear assembly, and a tube enclosure connected to the housing. The tube enclosure is configured to house a primary drug closure. The gear assembly includes a spool assembly having a pinion gear and a drive spool. When the spring rotates the drive spool, the drive spool drives the pinion gear, and the gear assembly drives the shuttle assembly. When the gear assembly drives the shuttle assembly, the shuttle assembly slides longitudinally along the housing. The gear assembly may be spring driven such that a spring rotates the pinion gear about the drive spool. The primary drug closure may be a syringe. An overspeed protection device is also provided which has a spool assembly including a drive spool having a plurality of cams, a spring, and a pinion gear with spiral cam surfaces.

An injection device for dispensing of a liquid medicament is disclosed. The device includes an elongated housing extending in an axial direction to accommodate a cartridge, a drive member axially displaceable inside the housing and being in sealed engagement with a side wall of the housing, wherein the drive member has an abutment face to axially abut with a proximal end of a barrel of the cartridge to displace the cartridge from the undeployed position towards the deployed position, wherein the drive member has an outlet located distally from the sealed engagement and further has an inlet located proximally from the sealed engagement, wherein the inlet and the outlet are in flow connection with each other via a flow path extending through the drive member and wherein at least one flow restrictor is arranged across or in the flow path.

Disclosed is a fluid injection device for a needle free syringe is provided that is spring-loadable and comprises a trigger positioned within the housing and actuated by depression of a push-button disposed opposite the dispensing end at an external actuation surface disposed transverse to the injection axis. The trigger has a trigger latch configured to release a trigger catch as heaving part of the spring-loaded piston of the device. The trigger catch is configured to urge the trigger latch in a direction transverse to the injection axis when the piston moves from the unloaded position to the loaded position. The compression spring is retained around the piston and retained within the housing by a piston head. The device further comprises a syringe adapter and a safety cap which prevents accidental triggering.

A cassette for use with an injector has a housing, and a cassette identification arrangement (cassette ID) defining a code containing information about the cassette that is detectable and decipherable by an injector. The cassette may further have a sleeve movably disposed within the housing, for holding a drug container, and a locking arrangement for interlocking the sleeve with the housing. The cassette may further have an aperture in the housing, and a cassette cap for removing a needle shield of the drug container. The cassette may have an anti-bending structure to prevent bending or flexing of the cassette cap. The injector may have a processor for controlling operational parameters of the injector and a detector communicatively coupled with the processor for detesting and communicating the cassette ID to the microprocessor to decipher the code defined therein. Also, a method of injecting a drug into a patient with an injector, wherein the sequence of actions performed by the user are controlled. Still further, a method of treating a patient in need thereof wherein a cassette containing a drug is provided and administered to the patient using an injector.

Handheld drug delivery devices for injection of a medicament into a target location are disclosed herein. The drug delivery devices of the present disclosure include drive mechanisms, needle insertion mechanisms, and fluid pathway connectors. These components may be arranged within a housing. The arrangement of these components may provide an easy to use device that is capable of delivering volumes larger than traditionally injected using syringes. Translation of a drug container of the device may cause connection of a fluid pathway from the drug container for delivery of a medicament to a target location.

A needle-free injector monitors the compression of a gas bubble within a cartridge of injectate during operating of a plunger in a pre-injection phase. When the gas bubble becomes sufficiently compressed (e.g., at or near the equilibrium pressure during the piercing phase), the velocity of the plunger of the needle-free injector is changed to the piercing rate for delivery of the injectate to a target. By detecting the gas bubble compression prior to delivery of injectate in this manner, an injection stream can be controlled to more closely reproduce a target injection profile. For example, the integrator error for an injector control model can be mitigated, stream acceleration can be optimized/maximized, and overshoot in the injector response (e.g., stream velocity or plunger movement) can be minimized.

An automatic injection control device injects fluid at a rate directly related to the displacement rate of the device body from a held positioning member. The device has a syringe end, a gripping end, a syringe barrel coupled to the body and a refillable reservoir and at least one directional valve at the syringe end of the body. The directional valves permitting refilling of the refillable reservoir without removing the syringe barrel. Also, a transmission system is coupled to the body, as well as the positioning member, a syringe plunging member, and a gearing mechanism linking the positioning member to the syringe plunging member. The device is designed so that when the positioning member is held in a fixed extended position and the body is pulled by the gripping end, the transmission system provides a one-way motion of the syringe plunging member to precisely inject fluid from the device.

An apparatus for injectate delivery includes a cartridge, a linear actuator, a rotary motor mechanically coupled the actuator, and a controller coupled to the motor. The controller controls a linear motion of the actuator by controlling an electrical input supplied to the motor in a first interval during which the motor is stationary with the linear actuator engaged with the cartridge to displace an injectate in the cartridge, a second interval following the first interval during which the controller accelerates the motor from stationary to a first speed selected to create a jet of the injectate from the cartridge with a velocity sufficient to pierce human tissue to a subcutaneous depth, a third interval during which the controller maintains the motor at or above the first speed, and a fourth interval during which the controller decelerates the motor to a second speed to deliver the injectate at the subcutaneous depth.